About HeraMED
HeraMED is a company based in Netanya (Israel) founded in 2011. HeraMED offers products and services including HeraCARE and HeraBEAT. HeraMED operates in a competitive market with competitors including kegg, Raydiant Oximetry, Femometer, Baymatob and OBMedical, among others.
- Headquarter Netanya, Israel
- Stage Public
-
Sectors
ConsumerTechnology Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Heramed Limited
-
Annual Revenue
$225.68 K (USD)-39.9as on Dec 31, 2024
-
Net Profit
-$3.4 M (USD)18.96as on Dec 31, 2024
-
EBITDA
-$3.25 M (USD)12.71as on Dec 31, 2024
-
Latest Funding Round
$1.25 M (USD), Post-IPO
Dec 15, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HeraMED
HeraMED is a publicly listed company on the ASX with ticker symbol HMD in Australia, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HeraMED
HeraMED offers a comprehensive portfolio of products and services, including HeraCARE and HeraBEAT.
Digital platform for remote maternity care management and telehealth services.
Smart device for capturing vital measurements in prenatal care.
People of HeraMED
Unlock access to complete
Funding Insights of HeraMED
Investments & Acquisitions by HeraMED
Investment portfolio details for HeraMED
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HeraMED
Detailed financials for HeraMED
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Heramed Comparisons
Peer comparison for HeraMED
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HeraMED
HeraMED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as kegg, Raydiant Oximetry, Femometer, Baymatob and OBMedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fertility tracking and pelvic health solutions are provided by kegg.
|
|
| Locked | Locked | Locked |
Wearable device for non-invasive fetal blood oxygen monitoring is offered.
|
|
| Locked | Locked | Locked |
Basal body temperature is tracked by Femometer for cycle monitoring.
|
|
| Locked | Locked | Locked |
AI-based health risk analysis is provided for pregnant women monitoring.
|
|
| Locked | Locked | Locked |
Fetal heart rate and contractions are monitored via wireless electrodes.
|
Detailed competitors of HeraMED
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Heramed
Complete news archive for HeraMED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeraMED
HeraMED was founded in 2011 and raised its 1st funding round 8 years after it was founded.
HeraMED is headquartered in Netanya, Israel. It is registered at Netanya, Central District, Israel.
Annual revenue of HeraMED is $225.68K as on Dec 31, 2024.
HeraMED was founded in 2011 and is located in Netanya, Israel. Operations are centered in the medical technology sector, where smartphone-based devices for pregnancy monitoring are developed and distributed. These tools enable users to track fetal heart rates and related metrics through mobile applications. The companys domain, hera-med.com, supports access to product information and resources. Focus remains on accessible health monitoring solutions for expectant mothers in various geographies.
HeraMED's top competitors include kegg, Raydiant Oximetry and Femometer.
HeraMED offers HeraCARE and HeraBEAT.
Yes, HeraMED is publicly traded on ASX under the ticker symbol HMD.
The ticker symbol of HeraMED is HMD on ASX.